Cargando…
The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial
BACKGROUND: The promotility agents currently available to treat gastroparesis and feed intolerance in the critically ill are limited by adverse effects. The aim of this study was to assess the pharmacodynamic effects and pharmacokinetics of single doses of the novel gastric promotility agent motilin...
Autores principales: | Chapman, Marianne J., Deane, Adam M., O’Connor, Stephanie L., Nguyen, Nam Q., Fraser, Robert J. L., Richards, Duncan B., Hacquoil, Kimberley E., Vasist Johnson, Lakshmi S., Barton, Matthew E., Dukes, George E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967996/ https://www.ncbi.nlm.nih.gov/pubmed/27476581 http://dx.doi.org/10.1186/s13054-016-1420-4 |
Ejemplares similares
-
Gastric emptying assessment in critically ill patients with feed intolerance; comparison of (13)C octanoic acid, paracetamol and 3-O-methylglucose absorption tests
por: Chapman, M, et al.
Publicado: (2012) -
A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease
por: Marrinan, Sarah L., et al.
Publicado: (2017) -
Structural basis for motilin and erythromycin recognition by motilin receptor
por: You, Chongzhao, et al.
Publicado: (2023) -
Frequency, determinants and impact of feed intolerance amongst the critically ill
por: Gungabissoon, U, et al.
Publicado: (2012) -
Effects of Motilin Receptor Agonists and Ghrelin in Human motilin receptor Transgenic Mice
por: Kawamura, Tomoe, et al.
Publicado: (2019)